The Patent Finder

Meltec Multi-Epitope-Ligand-Technologies GmbH

Also on record
Records under this name other than patents Meltec Multi-Epitope-Ligand-Technologies GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 9 of 9 · Back to Meltec Multi-Epitope-Ligand-Technologies GmbH

PatentTitleStatus Expires Confidence
US 6,150,173Automated determining and measuring device and method
Formerly held
Term ended
Term ended Jul 15, 2019 · From the USPTO record
Term endedTerm ended Jul 15, 2019From the USPTO record
US 7,676,328Method for identifying cell-specific proteins
Formerly held
Lapsed on the fee record
Ended Mar 9, 2014 · From the USPTO record
Lapsed on the fee recordEnded Mar 9, 2014From the USPTO record
US 6,974,675Process for identifying and enriching cell-specific target structures
Formerly held
Lapsed on the fee record
Ended Dec 13, 2013 · From the USPTO record
Lapsed on the fee recordEnded Dec 13, 2013From the USPTO record
US 6,924,115Process for identifying cell-specific target structures
Formerly held
Lapsed on the fee record
Ended Aug 2, 2013 · From the USPTO record
Lapsed on the fee recordEnded Aug 2, 2013From the USPTO record
US 6,875,579Device for binding molecules, molecular groups, molecular parts and/or cells
Formerly held
Lapsed on the fee record
Ended Apr 5, 2013 · From the USPTO record
Lapsed on the fee recordEnded Apr 5, 2013From the USPTO record
US 7,382,909Method for the automatic analysis of microscope images
Formerly held
Lapsed on the fee record
Ended Jun 3, 2012 · From the USPTO record
Lapsed on the fee recordEnded Jun 3, 2012From the USPTO record
US 6,649,165Method of blocking cytotoxic activity in patients with amyotrophic lateral sclerosis using soluble Fc&ggr;RIII receptors
Formerly held
Lapsed on the fee record
Ended Nov 18, 2007 · From the USPTO record
Lapsed on the fee recordEnded Nov 18, 2007From the USPTO record
US 6,638,506Method of blocking cytotoxic activity in patients with amyotrophic lateral sclerosis using antibodies to Fc&ggr;RIII
Formerly held
Lapsed on the fee record
Ended Oct 28, 2007 · From the USPTO record
Lapsed on the fee recordEnded Oct 28, 2007From the USPTO record
US 6,638,515Method of blocking cytotoxic activity in patients with amyotrophic lateral sclerosis using protein V
Formerly held
Lapsed on the fee record
Ended Oct 28, 2007 · From the USPTO record
Lapsed on the fee recordEnded Oct 28, 2007From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited